Article
CAR Macrophages for SARS-CoV-2 Immunotherapy
2020-07-27
Abstract excerpt
Targeted therapeutics for the treatment of coronavirus disease 2019 (COVID-19), especially severe cases, are currently lacking. As macrophages have unique effector functions as a first-line defense against invading pathogens, we genetically armed human macrophages with chimeric antigen receptors (CARs) to reprogram their phagocytic activity against SARS-CoV-2. After investigation of CAR constructs with different i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 801e9d43-b538-5dc0-9180-d547c30c1106
- DOI
- 10.1101/2020.07.26.222208
